CN106901382A - A kind of health care preparation for treating pregnant woman's flu - Google Patents
A kind of health care preparation for treating pregnant woman's flu Download PDFInfo
- Publication number
- CN106901382A CN106901382A CN201710108120.7A CN201710108120A CN106901382A CN 106901382 A CN106901382 A CN 106901382A CN 201710108120 A CN201710108120 A CN 201710108120A CN 106901382 A CN106901382 A CN 106901382A
- Authority
- CN
- China
- Prior art keywords
- parts
- health care
- care preparation
- flu
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 31
- 230000036541 health Effects 0.000 title claims abstract description 29
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 30
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 18
- 240000008042 Zea mays Species 0.000 claims abstract description 18
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 18
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 16
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 16
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims abstract description 16
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 16
- 235000009973 maize Nutrition 0.000 claims abstract description 16
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000016623 Fragaria vesca Nutrition 0.000 claims abstract description 15
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims abstract description 15
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 15
- 235000015203 fruit juice Nutrition 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 15
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 15
- 239000011718 vitamin C Substances 0.000 claims abstract description 15
- 229920002307 Dextran Polymers 0.000 claims description 15
- 241000220223 Fragaria Species 0.000 claims description 14
- 230000035935 pregnancy Effects 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 10
- 239000003814 drug Substances 0.000 abstract description 6
- 239000000203 mixture Substances 0.000 abstract description 6
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 235000013305 food Nutrition 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 235000005911 diet Nutrition 0.000 abstract description 3
- 230000037213 diet Effects 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 abstract 1
- 229920002498 Beta-glucan Polymers 0.000 abstract 1
- 240000009088 Fragaria x ananassa Species 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 description 11
- 150000001413 amino acids Chemical class 0.000 description 6
- 241000700605 Viruses Species 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000035240 Disease Resistance Diseases 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 238000011203 antimicrobial therapy Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000035605 chemotaxis Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000003170 nutritional factors Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides a kind of health care preparation for treating pregnant woman's flu, main components in percentage by weight is calculated as by weight：1,500 1600 parts of dietary fiber, yeast beta glucan and each 180 220 parts of maize oligopeptide, 25 35 parts of strawberry fruit juice powder, 25 parts of vitamin C, the composition of raw material of the present invention belongs to national new resource food, diet nutritional composition, there is no toxic and side effect to body, it is particularly suitable for pregnancy period crowd to take, can effectively lifts resistance of human body, can safer confrontation flu than medicine.
Description
Technical field
The invention belongs to technical field of health care food, and in particular to a kind of health care preparation for treating pregnant woman's flu.
Background technology
On existing pregnant baby's health-product market, for pregnancy period flu, the doctor and patient of specialty show to fear in pairs
Fear and worry.Because pregnancy period flu can cause many neonatal inborn defects.Pregnant mothers catch a cold this problem in face of the pregnancy period,
Treated without more preferable medicine again, because their drug administrations can not only hurt the health of fetus, can also bring disaster to parent
Health.
Caught a cold for the pregnancy period on the market at present, more experts treat improvement using the relatively small medicine of side effect,
But " there's no such thing as a totally safe medicine ", can not completely avoid side effects of pharmaceutical drugs.
The content of the invention
The present invention provides a kind of health care preparation for treating pregnant woman's flu to solve Problems Existing, poly- using yeast β-Portugal
Sugar, vitamin C, maize oligopeptide, strawberry fruit juice powder, dietary fiber, the composition of raw material belong to national new resource food, meals
Nutritional ingredient, does not have toxic and side effect to body, is particularly suitable for pregnancy period crowd and takes, and can effectively lift resistance of human body, compares medicine
Can safer confrontation flu.
What the present invention was achieved through the following technical solutions：
A kind of health care preparation for treating pregnant woman's flu, main components in percentage by weight is calculated as by weight：Dietary fiber 1500-1600
Part, yeast beta-dextran and maize oligopeptide are each 180-220 parts, 25-35 parts, vitamin C 2-5 parts of strawberry fruit juice powder.
Used as the further preferred of above-mentioned technical proposal, health care preparation main components in percentage by weight is by weight：Dietary fiber
1550-1580 parts, yeast beta-dextran and maize oligopeptide are each 190-210 parts, 25-30 parts of strawberry fruit juice powder, vitamin C 3-4
Part.
Further preferred such scheme, the health care preparation main component optimum proportioning is calculated as by weight：Dietary fiber
1567 parts, yeast beta-dextran and each 200 parts of maize oligopeptide, 30 parts of strawberry fruit juice powder, 3 parts of vitamin C.
The health care preparation is made powderous preparations according to prior art.
The dietary fiber is water-soluble dietary fiber, can increase gastrointestinal motility, is conducive to enteron aisle more preferably to absorb battalion
Support, while being also beneficial to prevent constipation.
The yeast beta-dextran is the polymer that the mode of 3- keys is combined, with uniqueness by β -1 by d- glucose
Molecular structure, generally exist with the conformation of triple helix, with congenital immunity ability energy activated macrophage, NK cells so as to
Phagocytosis exogenous virus, bacterium, killing tumor cell；Meanwhile, the special structure of yeast beta-dextran has unique targeting special
Point, can quickly activate immune supervision and the recognition mechanism of body itself, so as to strengthen their fighting capacity, make autoimmunity system
System reaches optimum balance state, and these two aspects is acted on simultaneously, rapid within the shortest time to improve human disease resistance, keeps body
Health；Yeast dextran can significantly reduce human body triglyceride levels, reduce the low-density lipoprotein (fat rich in cholesterol
Albumen) level, and increasing high density lipoprotein (lipoprotein of antiatherosclerosis) level, effectively prevent coronary heart disease, artery
The cardiovascular and cerebrovascular diseases such as hardening；Antitumor yeast dextran is suppressed or kills tumour indirectly by strengthening the immunologic function of body
Cell.
The maize oligopeptide contains the necessary various amino acid of human body, there is provided amino acid and peptide energy nutrition, corn peptide ammonia
The composition GLN content of base acid is very high, and glutamine is the amino acid for constituting protein, is again the nitrogen source of nucleic acid,
It is closely related with tissue growth, reparation, though being nonessential amino acid, improving immunity of organisms, maintaining intestinal mucosa normal
Structure and function, the ability for improving organism adaptation external world destructive stimulus all have important value；In addition, corn peptide has suppresses blood
The effect of ACE, such that it is able to adjust blood pressure balance.Maize oligopeptide is easy to absorb better than amino acid or albumen
The absorption of matter, it is completely soluble under PH on a large scale, produced without turbid phenomenon and sediment, to thermally-stabilised, component does not change, work(
Can not lose, wholefood albumen is safe and reliable, has no toxic side effect.
The vitamin is that human body maintains eubolism and one of six big nutritional factors necessary to function, and vitamin C is made
It is a kind of water soluble vitamin, the various redox reactions of human body, material synthesis and function of detoxification is participated in, while it can be with
Reduce the resistance of permeability, antihistamine and increase to infection of capillary.Specific effect is as follows：Improve the immune of human body
Power：Leucocyte contains abundant VC, and when body receives courses of infection, intraleukocytic VC is drastically reduced, and VC can strengthen neutral grain
Germ ability is killed in the chemotaxis and deformability of cell, raising；Promote the generation of lymphoblast, improve body to external and evil
Become the identification and killing of cell；Participate in the synthesis of immunoglobulin；The generation of promotion interferon, the transcription of viral interference mRNA,
Suppress the hyperplasia of virus.Interferon (IFN) is a kind of broad-spectrum disease resistance toxic agent, not direct killing or suppression virus, and is mainly
Being acted on by cell surface receptor makes cell produce antiviral protein, so as to suppress the duplication of virus.
The strawberry fruit juice powder is of high nutritive value, and effect of digestion is contributed to containing abundant vitamin C.
The present invention with dietary fiber as efficacy-enhancing ingredient, add can not only antimicrobial therapy flu can with the yeast β of enhance immunity-
Glucan, the maize oligopeptide that amino acid and peptide energy nutrition are provided and the vitamin C for being capable of suppressing virus replication, in order that this
The mouthfeel of formula is more delicious to be additionally added pure natural strawberry fruit juice powder, without any addition, keeps original taste state, formula components to belong to
National new resource food, is complemented each other, and effectively flu is treated while providing diet nutritional composition to pregnant woman, to body without poison
Side effect.
Beneficial effects of the present invention are：
A kind of health care preparation for treating pregnant woman's flu that the present invention is provided, it is diet nutritional composition to be formulated, and is not had to body
Toxic and side effect, is particularly suitable for pregnancy period crowd and takes, and can effectively lift resistance of human body, can safer confrontation flu than medicine.
Specific embodiment
Embodiment 1
1567 parts of dietary fiber, yeast beta-dextran and each 200 parts of maize oligopeptide, 30 parts of strawberry fruit juice powder, vitamin C
3 parts；
The health care preparation is made powderous preparations according to prior art.
Embodiment 2
1500 parts of dietary fiber, yeast beta-dextran and each 180 parts of maize oligopeptide, 25 parts of strawberry fruit juice powder, vitamin C
2 parts；
The health care preparation is made powderous preparations according to prior art.
Embodiment 3
1600 parts of dietary fiber, yeast beta-dextran and each 220 parts of maize oligopeptide, 35 parts of strawberry fruit juice powder, vitamin
C5 parts；
The health care preparation is made powderous preparations according to prior art.
Embodiment 4
1550 parts of dietary fiber, yeast beta-dextran and each 190 parts of maize oligopeptide, 25 parts of strawberry fruit juice powder, vitamin C
3 parts；
The health care preparation is made powderous preparations according to prior art.
Embodiment 5
1580 parts of dietary fiber, yeast beta-dextran and each 210 parts of maize oligopeptide, 30 parts of strawberry fruit juice powder, vitamin C
4 parts；
The health care preparation is made powderous preparations according to prior art.
The result of clinical observation of the present invention is as follows：
The cold patients of 25 Early placental phases take the health care preparation in the embodiment of the present invention 1, used as treating 1 group；25
The cold patients of second trimester of pregnancy take the health care preparation in the embodiment of the present invention 2, used as treating 2 groups；25 senses of second trimester of pregnancy
The health care preparation during patient takes the embodiment of the present invention 3 is emitted, as treating 3 groups；25 cold patients of latter half of gestation clothes are originally
Health care preparation in inventive embodiments 4, as treating 4 groups；The cold patients of 25 latter half of gestation clothes take the embodiment of the present invention 5
In health care preparation, as treating 5 groups.
Result after health care preparation one week is taken：
| Group | It has been sustained | Effectively | It is effective | It is invalid | Have no side effect |
| One group | 1 | 1 | 23 | 0 | Nothing |
| Two groups | 1 | 2 | 21 | 1 | Nothing |
| Three groups | 1 | 2 | 21 | 1 | Nothing |
| Four groups | 1 | 2 | 21 | 1 | Nothing |
| Five groups | 1 | 1 | 21 | 2 | Nothing |
As seen from the above table, embodiment 1 is optimum embodiment, takes health care preparation of the present invention, there is obvious therapeutic effect.
Specific embodiment of the invention is the foregoing is only, is not intended to limit the invention, for this area
For technical staff, the present invention can have various modifications and variations.It is all made within the spirit and principles in the present invention it is any
Modification, equivalent, improvement etc., should be included within the scope of the present invention.
Claims (3)
- It is 1. a kind of to treat the health care preparation that pregnant woman catches a cold, it is characterised in that：Main components in percentage by weight is calculated as by weight：Dietary fiber 1500-1600 parts, yeast beta-dextran and maize oligopeptide is each 180-220 parts, 25-35 parts of strawberry fruit juice powder, vitamin C 2-5 Part.
- 2. the health care preparation that treatment pregnant woman according to claim 1 catches a cold, it is characterised in that：Main components in percentage by weight is by weight Part is calculated as：Dietary fiber 1550-1580 parts, yeast beta-dextran and maize oligopeptide is each 190-210 parts, strawberry fruit juice powder 25- 30 parts, vitamin C 3-4 parts.
- 3. the health care preparation that treatment pregnant woman according to claim 1 catches a cold, it is characterised in that：Main components in percentage by weight is by weight Part is calculated as：1567 parts of dietary fiber, yeast beta-dextran and each 200 parts of maize oligopeptide, 30 parts of strawberry fruit juice powder, vitamin C 3 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710108120.7A CN106901382A (en) | 2017-02-27 | 2017-02-27 | A kind of health care preparation for treating pregnant woman's flu |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710108120.7A CN106901382A (en) | 2017-02-27 | 2017-02-27 | A kind of health care preparation for treating pregnant woman's flu |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106901382A true CN106901382A (en) | 2017-06-30 |
Family
ID=59208971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710108120.7A Pending CN106901382A (en) | 2017-02-27 | 2017-02-27 | A kind of health care preparation for treating pregnant woman's flu |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106901382A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109363037A (en) * | 2018-12-06 | 2019-02-22 | 王金明 | It is a kind of multi-functional containing peptide beverage |
| CN109907264A (en) * | 2019-04-12 | 2019-06-21 | 吉林省九圣源生物科技有限公司 | A kind of herbal cuisine eaten for common cold crowd |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105124549A (en) * | 2015-07-29 | 2015-12-09 | 广州施健生物科技有限公司 | Nutritional composition for reducing radiation hazards and preparation method thereof |
| CN104146248B (en) * | 2014-07-30 | 2016-06-01 | 广州施健生物科技有限公司 | A kind of immunity nourishment composition and application thereof |
| CN105727081A (en) * | 2016-04-26 | 2016-07-06 | 广州正广生物科技有限公司 | Healthcare product composition for treating gout |
| CN106173572A (en) * | 2015-04-30 | 2016-12-07 | 北京斯利安药业有限公司 | A kind of maternal nutritional fortified compositions and preparation method thereof |
-
2017
- 2017-02-27 CN CN201710108120.7A patent/CN106901382A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104146248B (en) * | 2014-07-30 | 2016-06-01 | 广州施健生物科技有限公司 | A kind of immunity nourishment composition and application thereof |
| CN106173572A (en) * | 2015-04-30 | 2016-12-07 | 北京斯利安药业有限公司 | A kind of maternal nutritional fortified compositions and preparation method thereof |
| CN105124549A (en) * | 2015-07-29 | 2015-12-09 | 广州施健生物科技有限公司 | Nutritional composition for reducing radiation hazards and preparation method thereof |
| CN105727081A (en) * | 2016-04-26 | 2016-07-06 | 广州正广生物科技有限公司 | Healthcare product composition for treating gout |
Non-Patent Citations (1)
| Title |
|---|
| 郭永等: "酵母β-葡聚糖的生物活性及开发利用", 《中国食物与营养》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109363037A (en) * | 2018-12-06 | 2019-02-22 | 王金明 | It is a kind of multi-functional containing peptide beverage |
| CN109907264A (en) * | 2019-04-12 | 2019-06-21 | 吉林省九圣源生物科技有限公司 | A kind of herbal cuisine eaten for common cold crowd |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105495258B (en) | A kind of fruit beverage for helping anti-trioxypurine | |
| CN104107424B (en) | Qi cultivating thrombolytic medicinal composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof | |
| CN103861070B (en) | Health product for preventing angiosclerosis | |
| CN102144748A (en) | Five-color flour food with functions of excreting toxins, protecting liver and maintaining beauty | |
| CN109550040A (en) | A kind of Chinese medicine peptide composition of strengthen immunity | |
| CN101664136A (en) | Method for preparing high-activity nutrient natto and application of high-activity nutrient natto | |
| CN112057560A (en) | Ganoderma lucidum spore dendrobium nobile composition capable of enhancing immunity and preparation method and application thereof | |
| US8501264B2 (en) | Papaya puree and uses thereof | |
| WO2004112773A1 (en) | Pharmaceutical compositions used for immune disease treatment and improvement | |
| CN106901382A (en) | A kind of health care preparation for treating pregnant woman's flu | |
| CN102090637A (en) | Collagen-containing compound nutritious powder | |
| CN108524901B (en) | Fermented clear liquid for relieving cold in uterus and preparation method and application thereof | |
| KR20060127874A (en) | Enteropathy ameliorating composition | |
| CN109645295A (en) | A kind of Astaxanthin In Haematococcus Pluvialis solid beverage maintaining cardiovascular system health | |
| CN107184656A (en) | It is a kind of to be used for hypotensive, blood fat, tea of blood glucose and preparation method thereof | |
| CN112168869A (en) | Formic acid traditional Chinese medicine and preparation method thereof | |
| CN112352945A (en) | Artificial cordyceps militaris food with effects of resisting fatigue and improving immunity | |
| KR101093006B1 (en) | Method for producing functional health food containing bezoar bovis used microbes and the functional health food produced by the same | |
| CN1233417A (en) | Health-care food for diabetics | |
| CN103948591B (en) | A kind of slimming agents | |
| CN108434158A (en) | Application and drug of the 2-acetylamino-2-deoxy-D-glucose in preparing prevention atherosclerosis drug and health products | |
| CN111528386B (en) | Hawthorn and natto solid beverage and preparation method thereof | |
| CN105664096A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN100569252C (en) | The medicine and the preparation method of treatment essential hypertension | |
| CN113559215A (en) | Medicine for improving human body excretion and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170630 |
|
| WD01 | Invention patent application deemed withdrawn after publication |